Edelweiss MSCI I D & W H 45 Index Fund-Dir(IDCW)

Edelweiss MSCI I D & W H 45 Index Fund-Dir(IDCW)- Performance(%)

* returns above 1 yr. are annualized

	1w	1m	3m	6m	1y	3y	5y	Since INC
Scheme Returns	-2.42	1.07	5.62	18.98	37.96	13.58		16.72
Category Avg	-2.80	2.48	5.47	19.74	42.84	18.02	14.50	19.53
Category Best	-0.79	11.03	16.28	46.55	88.73	29.38	17.52	81.07
Category Worst	-2.42	1.07	5.62	18.98	37.96	13.58		16.72

Fund Holdings

Asset Type	Instrument Name	Industry	Net Assets(%)	No of Shares	Mkt Value(Cr.)
Equity & Equity related Investments
Equity	Sun Pharma.Inds.	Pharmaceuticals & Biotechnology	14.85	1,31,214.00	21.26
Equity	Cipla	Pharmaceuticals & Biotechnology	7.50	71,748.00	10.74
Equity	Dr Reddy's Labs	Pharmaceuticals & Biotechnology	6.87	15,963.00	9.83
Equity	Apollo Hospitals	Healthcare Services	6.16	13,882.00	8.82
Equity	Max Healthcare	Healthcare Services	6.09	1,06,294.00	8.71
Foreign Equity	ELI LILLY & CO	Pharmaceuticals	5.11	1,128.00	7.32
Equity	Divi's Lab.	Pharmaceuticals & Biotechnology	3.94	16,384.00	5.64
Equity	Lupin	Pharmaceuticals & Biotechnology	3.51	31,126.00	5.03
Foreign Equity	JOHNSON & JOHNSON	Pharmaceuticals	3.10	3,366.00	4.44
Equity	Aurobindo Pharma	Pharmaceuticals & Biotechnology	2.75	36,103.00	3.93
Foreign Equity	MERCK & CO.INC	Pharmaceuticals	2.72	3,544.00	3.90
Foreign Equity	ABBVIE INC	Biotechnology	2.62	2,469.00	3.75
Equity	Torrent Pharma.	Pharmaceuticals & Biotechnology	2.52	13,882.00	3.61
Foreign Equity	THERMO FISHER SCIENTIFIC INC	Life Sciences Tools & Services	1.83	541.00	2.62
Equity	Fortis Health.	Healthcare Services	1.82	62,174.00	2.61
Equity	Ipca Labs.	Pharmaceuticals & Biotechnology	1.66	19,160.00	2.37
Foreign Equity	NOVARTIS AG	Pharmaceuticals	1.62	2,868.00	2.31
Foreign Equity	ABBOTT LABORATORIES	Health Care Equipment & Supplies	1.61	2,429.00	2.30
Foreign Equity	DANAHER CORP	Health Care Equipment & Supplies	1.43	982.00	2.04
Equity	Laurus Labs	Pharmaceuticals & Biotechnology	1.31	47,897.00	1.88
Equity	Glenmark Pharma.	Pharmaceuticals & Biotechnology	1.30	19,350.00	1.85
Foreign Equity	AMGEN INC	Biotechnology	1.24	748.00	1.77
Equity	Syngene Intl.	Healthcare Services	1.22	24,800.00	1.74
Foreign Equity	INTUITIVE SURGICAL INC	Health Care Equipment & Supplies	1.15	493.00	1.64
Equity	J B Chem & Pharm	Pharmaceuticals & Biotechnology	1.11	9,607.00	1.59
Equity	Biocon	Pharmaceuticals & Biotechnology	1.06	57,210.00	1.51
Equity	Gland Pharma	Pharmaceuticals & Biotechnology	1.02	7,903.00	1.46
Equity	Global Health	Healthcare Services	1.02	11,010.00	1.45
Foreign Equity	STRYKER CORP	Health Care Equipment & Supplies	1.00	479.00	1.43
Equity	Ajanta Pharma	Pharmaceuticals & Biotechnology	0.95	6,069.00	1.35
Foreign Equity	MEDTRONIC PLC	Health Care Equipment & Supplies	0.94	1,861.00	1.35
Foreign Equity	VERTEX PHARMACEUTICALS INC	Biotechnology	0.88	360.00	1.25
Equity	Narayana Hrudaya	Healthcare Services	0.88	9,778.00	1.26
Equity	Dr Lal Pathlabs	Healthcare Services	0.82	5,201.00	1.18
Equity	Glaxosmi. Pharma	Pharmaceuticals & Biotechnology	0.79	5,790.00	1.13
Foreign Equity	GILEAD SCIENCES INC	Biotechnology	0.74	1,743.00	1.06
Equity	Suven Pharma	Pharmaceuticals & Biotechnology	0.66	13,922.00	0.94
Equity	Sanofi India	Pharmaceuticals & Biotechnology	0.63	1,113.00	0.90
Foreign Equity	BECTON DICKINSON & CO	Health Care Equipment & Supplies	0.58	405.00	0.84
Equity	Pfizer	Pharmaceuticals & Biotechnology	0.55	1,876.00	0.79
Foreign Equity	IQVIA HOLDINGS INC	Life Sciences Tools & Services	0.38	256.00	0.54
Foreign Equity	AGILENT TECHNOLOGIES INC	Life Sciences Tools & Services	0.35	411.00	0.50
Foreign Equity	MODERNA INC	PHARMACEUTICALS	0.28	454.00	0.40
Foreign Equity	ILLUMINA INC	Life Sciences Tools & Services	0.18	222.00	0.25
Foreign Equity	NOVO-NORDISK A/S	-/-	0.01	10.00	0.01
Cash & Cash Equivalent
Net CA & Others	Net CA & Others	-/-	1.12	0.00	1.66
Reverse Repo	C C I	-/-	0.12	0.00	0.17
Cash & Cash Equivalent	Accrued Interest	-/-	0.00	0.00	0.00

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.